← Back to guidelines
Plastic Surgery9 papers

Bizarre parosteal osteochondromatous proliferation

Last edited: 2 h ago

Overview

Bizarre parosteal osteochondromatous proliferation (BPOP), also known as Nora's lesion, is a rare benign reactive lesion typically affecting the bones of the hands and feet, particularly the toes and fingers. Clinically significant due to its aggressive radiographic appearance and potential for mimicking malignant conditions, BPOP poses diagnostic challenges and requires careful differentiation from other lesions. It predominantly affects adolescents and young adults, leading to localized swelling, pain, and ulceration that can mimic more serious pathologies such as osteomyelitis or chondrosarcoma. Accurate diagnosis and management are crucial in day-to-day practice to avoid unnecessary aggressive treatments and ensure appropriate surgical intervention when needed 2.

Pathophysiology

BPOP arises from reactive changes in the periosteum and cortical bone, often triggered by chronic irritation or trauma. The underlying mechanism involves an exaggerated reparative response characterized by endochondral ossification and the proliferation of fibrovascular tissue. This process leads to the formation of a mass that can extend into the medullary cavity, creating a distinctive radiographic appearance. Molecularly, the lesion showcases binucleated chondrocytes and areas of active bone formation, indicative of a complex interplay between inflammatory mediators and growth factors that stimulate abnormal bone and cartilage development 2. The exact triggers remain unclear but may involve repetitive mechanical stress or minor trauma, initiating a cascade of cellular activities that result in the characteristic lesion morphology 2.

Epidemiology

BPOP is exceedingly rare, with limited epidemiological data available. It predominantly affects adolescents and young adults, with a slight female predominance noted in some case series. Geographic distribution does not appear to show significant variations, suggesting a sporadic occurrence rather than a geographically influenced pattern. There are no well-documented risk factors beyond local trauma or irritation, though the exact incidence and prevalence remain underreported due to its rarity and diagnostic challenges 2.

Clinical Presentation

Patients typically present with a hard, localized swelling that can be ulcerated, especially over bony prominences like the distal phalanx of the toes or fingers. Pain and tenderness are common symptoms, often leading to functional impairment. Radiographically, BPOP can mimic more aggressive conditions due to its aggressive appearance, including cortical bone involvement and medullary extension. Atypical presentations may include deeper soft tissue involvement or less common locations outside the hands and feet, complicating initial clinical assessment 2.

Diagnosis

Diagnosis of BPOP relies heavily on clinical presentation and imaging findings, followed by histopathological confirmation. Key diagnostic criteria include:
  • Clinical Features: Hard, ulcerated swelling over bony prominences, often in the toes or fingers.
  • Imaging: Radiographic features showing corticomedullary continuity with underlying bone, suggesting extension into the medullary cavity. MRI may reveal intramedullary inflammatory extension and characteristic enhancement patterns.
  • Histopathology: Essential for definitive diagnosis, showing binucleated chondrocytes, endochondral ossification, and characteristic "blue bone" areas.
  • Required Tests:
  • - Radiographic Imaging: X-rays and MRI to assess lesion extent and characteristics. - Histopathological Examination: Biopsy necessary for confirmation.
  • Differential Diagnosis:
  • - Osteochondroma: Typically has a stalk and less aggressive radiographic appearance. - Subungual Exostosis: Usually more localized and less likely to extend medullary involvement. - Osteomyelitis: Presence of systemic signs, elevated inflammatory markers, and different histopathological features. - Chondrosarcoma: More aggressive growth pattern, atypical cells, and lack of reactive bone formation 2.

    Management

    Initial Management

  • Surgical Excision: Primary treatment involves complete surgical excision of the lesion to prevent recurrence.
  • - Specifics: Wide local excision ensuring clear margins around the lesion. - Monitoring: Postoperative imaging to confirm complete removal and absence of residual lesion.

    Follow-Up and Recurrence Prevention

  • Regular Follow-Up: Scheduled clinical and radiographic evaluations to monitor for recurrence.
  • - Intervals: Initial follow-up at 3 months, then annually for at least 2 years post-surgery. - Monitoring: Pain assessment, physical examination, and imaging studies to detect any signs of recurrence early.

    Refractory Cases

  • Referral to Specialist: If recurrence occurs or atypical features are noted, referral to orthopedic oncology or musculoskeletal pathology specialists is recommended.
  • - Consultation: For complex cases or those with atypical presentations. - Further Evaluation: Additional imaging or advanced histopathological analysis may be required.

    Complications

  • Recurrent Lesions: Common complication, necessitating vigilant follow-up.
  • - Management Trigger: Any clinical or radiographic signs of recurrence should prompt immediate reevaluation.
  • Infection: Risk associated with surgical intervention.
  • - Prevention: Adequate surgical technique, prophylactic antibiotics, and postoperative wound care.
  • Functional Impairment: Persistent pain or deformity can affect daily activities.
  • - Management: Pain management strategies and physical therapy if needed.

    Prognosis & Follow-Up

    The prognosis for BPOP is generally good following complete surgical excision, with low recurrence rates reported in most series. Prognostic indicators include the completeness of surgical resection and absence of residual disease. Recommended follow-up intervals typically involve clinical assessments and imaging at 3 months post-surgery, followed by annual evaluations for at least two years to ensure no recurrence 2.

    Special Populations

  • Pediatric Patients: BPOP predominantly affects adolescents, requiring careful surgical planning to minimize functional impact.
  • - Considerations: Growth plate preservation and minimizing trauma to developing bones.
  • Elderly: Less commonly reported but may present with atypical features due to comorbid conditions affecting healing and recovery.
  • - Management: Tailored surgical approaches considering overall health status and potential complications.

    Key Recommendations

  • Surgical Excision: Wide local excision with clear margins is recommended for definitive treatment 2.
  • (Evidence: Strong)
  • Histopathological Confirmation: Essential for ruling out malignant conditions 2.
  • (Evidence: Strong)
  • Radiographic Imaging: Use MRI and X-rays to assess lesion extent and characteristics preoperatively 2.
  • (Evidence: Moderate)
  • Regular Follow-Up: Schedule postoperative evaluations at 3 months and annually for 2 years to monitor for recurrence 2.
  • (Evidence: Moderate)
  • Referral for Recurrence: Refer to orthopedic oncology specialists if recurrence or atypical features are noted 2.
  • (Evidence: Expert opinion)
  • Preoperative Planning: Consider functional impact, especially in pediatric patients, to preserve growth potential 2.
  • (Evidence: Expert opinion)
  • Postoperative Care: Include prophylactic antibiotics and meticulous wound care to prevent infection 2.
  • (Evidence: Moderate)

    References

    1 Lee KM, Ko EA, Shah M, Oh SE, Lee JW, Park BK et al.. Overgrowth of long bone in rabbits by growth stimulation through metaphyseal hole creation. Scientific reports 2023. link 2 Yadav SK, Chandel A, Elhence PA, Sharma R. Atypical radiological presentation of bizarre parosteal osteochondromatous proliferation (BPOP) of the great toe. BMJ case reports 2026. link 3 Chocron Y, Alabdulkarim A, Gilardino MS. Patient-Specific Implants and Fat Grafting for Contour Deformities Post Craniosynostosis Reconstruction: A Therapeutic Approach. The Journal of craniofacial surgery 2023. link 4 Senatov F, Amanbek G, Orlova P, Bartov M, Grunina T, Kolesnikov E et al.. Biomimetic UHMWPE/HA scaffolds with rhBMP-2 and erythropoietin for reconstructive surgery. Materials science & engineering. C, Materials for biological applications 2020. link 5 Wang CC, Yang KC, Lin KH, Wu CC, Liu YL, Lin FH et al.. A biomimetic honeycomb-like scaffold prepared by flow-focusing technology for cartilage regeneration. Biotechnology and bioengineering 2014. link 6 Tsailas PG, Babis GC, Nikolopoulos K, Soucacos PN, Korres DS. The effectiveness of two COX-2 inhibitors in the prophylaxis against heterotopic new bone formation: an experimental study in rabbits. The Journal of surgical research 2009. link 7 Tamimi F, Torres J, Kathan C, Baca R, Clemente C, Blanco L et al.. Bone regeneration in rabbit calvaria with novel monetite granules. Journal of biomedical materials research. Part A 2008. link 8 Choi BH, Im CJ, Huh JY, Suh JJ, Lee SH. Effect of platelet-rich plasma on bone regeneration in autogenous bone graft. International journal of oral and maxillofacial surgery 2004. link 9 Orui H, Ishikawa A, Tsuchiya T, Ogino T. Magnetic resonance imaging characteristics of bizarre parosteal osteochondromatous proliferation of the hand: a case report. The Journal of hand surgery 2002. link

    Original source

    1. [1]
      Overgrowth of long bone in rabbits by growth stimulation through metaphyseal hole creation.Lee KM, Ko EA, Shah M, Oh SE, Lee JW, Park BK et al. Scientific reports (2023)
    2. [2]
    3. [3]
      Patient-Specific Implants and Fat Grafting for Contour Deformities Post Craniosynostosis Reconstruction: A Therapeutic Approach.Chocron Y, Alabdulkarim A, Gilardino MS The Journal of craniofacial surgery (2023)
    4. [4]
      Biomimetic UHMWPE/HA scaffolds with rhBMP-2 and erythropoietin for reconstructive surgery.Senatov F, Amanbek G, Orlova P, Bartov M, Grunina T, Kolesnikov E et al. Materials science & engineering. C, Materials for biological applications (2020)
    5. [5]
      A biomimetic honeycomb-like scaffold prepared by flow-focusing technology for cartilage regeneration.Wang CC, Yang KC, Lin KH, Wu CC, Liu YL, Lin FH et al. Biotechnology and bioengineering (2014)
    6. [6]
      The effectiveness of two COX-2 inhibitors in the prophylaxis against heterotopic new bone formation: an experimental study in rabbits.Tsailas PG, Babis GC, Nikolopoulos K, Soucacos PN, Korres DS The Journal of surgical research (2009)
    7. [7]
      Bone regeneration in rabbit calvaria with novel monetite granules.Tamimi F, Torres J, Kathan C, Baca R, Clemente C, Blanco L et al. Journal of biomedical materials research. Part A (2008)
    8. [8]
      Effect of platelet-rich plasma on bone regeneration in autogenous bone graft.Choi BH, Im CJ, Huh JY, Suh JJ, Lee SH International journal of oral and maxillofacial surgery (2004)
    9. [9]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG